Christoph Springfeld

Also affiliated with University Hospital Heidelberg, National Center for Tumor Diseases

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)”.

O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

Annals of Oncology(2023)10.1016/j.annonc.2023.04.017

N/A

0DataRank · unranked

5 citations

I. Bazin, Do‐Youn Oh, O. Zubkov, V. Breder, Li‐Yuan Bai +16 more